RAS Mutations in Thyroid Cancer
Authors:
- 19 July 2013
- journal article
- review article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 18 (8) , 926-932
Abstract
Learning Objectives: Explain the role of RAS mutations in thyroid carcinogenesis. Describe the histologic spectrum and prognostic implications of RAS-associated thyroid neoplasms. Explain the role of RAS mutation testing in patient care management algorithms.Keywords
This publication has 58 references indexed in Scilit:
- SomaticRASMutations Occur in a Large Proportion of SporadicRET-Negative Medullary Thyroid Carcinomas and Extend to a Previously Unidentified ExonThe Journal of Clinical Endocrinology & Metabolism, 2012
- Impact of Mutational Testing on the Diagnosis and Management of Patients with Cytologically Indeterminate Thyroid Nodules: A Prospective Analysis of 1056 FNA SamplesThe Journal of Clinical Endocrinology & Metabolism, 2011
- Molecular Testing for Somatic Mutations Improves the Accuracy of Thyroid Fine‐needle Aspiration BiopsyWorld Journal of Surgery, 2010
- Genetic Alterations in the Phosphatidylinositol-3 Kinase/Akt Pathway in Thyroid CancerThyroid®, 2010
- Molecular Testing for Mutations in Improving the Fine-Needle Aspiration Diagnosis of Thyroid NodulesThe Journal of Clinical Endocrinology & Metabolism, 2009
- Thyroid carcinoma: molecular pathways and therapeutic targetsLaboratory Investigation, 2008
- The National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference: a SummationCytojournal, 2008
- The Prevalence and Prognostic Value of BRAF Mutation in Thyroid CancerAnnals of Surgery, 2007
- Increasing Incidence of Thyroid Cancer in the United States, 1973-2002JAMA, 2006
- Selective activation of ras oncogenes in follicular and undifferentiated thyroid carcinomasEuropean Journal of Cancer, 1994